Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Oscier

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Drugs|October 4, 2003
Oral fludarabine: a viewpoint by David OscierDavid Oscier
Hematology (Amsterdam, Netherlands)|September 29, 2005
Biology and prognostic factors in CLLDavid Oscier
Best Practice & Research. Clinical Haematology|March 15, 2017
Clonal B-cell lymphocytosis of marginal zone originAliki Xochelli, David Oscier, Kostas Stamatopoulos
Blood Reviews|December 2, 2004
Splenic marginal zone lymphomaDavid Oscier, Roger Owen, Stephen Johnson
British Journal of Haematology|November 25, 2003
History revisitedCedric Ghevaert, David Oscier, Neil Hopkinson
British Journal of Haematology|October 13, 2015
The long-term outcome of patients in the LRF CLL4 trial: the effect of salvage treatment and biological markers in those surviving 10 yearsMonica Else, Rachel Wade, David Oscier, et al.
Cancers|February 15, 2022
The Genomics of Hairy Cell Leukaemia and Splenic Diffuse Red Pulp LymphomaDavid Oscier, Kostas Stamatopoulos, Amatta Mirandari, et al.
Leukemia & Lymphoma|November 3, 2005
ZAP-70 in B cell malignanciesJenny Orchard, Rachel Ibbotson, Giles Best, et al.
Blood|October 24, 2002
Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemiaStuart Lanham, Terry Hamblin, David Oscier, et al.
Leukemia & Lymphoma|May 7, 2014
Splenic marginal-zone lymphoma: ontogeny and geneticsPanagiotis Baliakas, Jonathan C Strefford, Vasilis Bikos, et al.
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Drugs|October 4, 2003
Oral fludarabine: a viewpoint by David OscierDavid Oscier
Hematology (Amsterdam, Netherlands)|September 29, 2005
Biology and prognostic factors in CLLDavid Oscier
Best Practice & Research. Clinical Haematology|March 15, 2017
Clonal B-cell lymphocytosis of marginal zone originAliki Xochelli, David Oscier, Kostas Stamatopoulos
Blood Reviews|December 2, 2004
Splenic marginal zone lymphomaDavid Oscier, Roger Owen, Stephen Johnson
British Journal of Haematology|November 25, 2003
History revisitedCedric Ghevaert, David Oscier, Neil Hopkinson
British Journal of Haematology|October 13, 2015
The long-term outcome of patients in the LRF CLL4 trial: the effect of salvage treatment and biological markers in those surviving 10 yearsMonica Else, Rachel Wade, David Oscier, et al.
Cancers|February 15, 2022
The Genomics of Hairy Cell Leukaemia and Splenic Diffuse Red Pulp LymphomaDavid Oscier, Kostas Stamatopoulos, Amatta Mirandari, et al.
Leukemia & Lymphoma|November 3, 2005
ZAP-70 in B cell malignanciesJenny Orchard, Rachel Ibbotson, Giles Best, et al.
Blood|October 24, 2002
Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemiaStuart Lanham, Terry Hamblin, David Oscier, et al.
Leukemia & Lymphoma|May 7, 2014
Splenic marginal-zone lymphoma: ontogeny and geneticsPanagiotis Baliakas, Jonathan C Strefford, Vasilis Bikos, et al.
Pageof 10